Clinical Analyzer

Clinical Analyzer Market Outlook

The global clinical analyzer market is projected to reach approximately USD 15.7 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2025 to 2035. This growth can be attributed to several factors, including the increasing prevalence of chronic diseases, a growing focus on preventive healthcare, and advancements in technology that enhance the efficiency and accuracy of diagnostic testing. Additionally, the expansion of healthcare infrastructure in emerging economies and the rising demand for point-of-care testing further contribute to the market's robust expansion. The integration of automation and artificial intelligence in laboratory processes is anticipated to revolutionize clinical diagnostics, pushing the boundaries of efficiency and precision in clinical analysis.

Growth Factor of the Market

One of the primary growth factors driving the clinical analyzer market is the increasing prevalence of chronic and infectious diseases worldwide. Conditions such as diabetes, cardiovascular diseases, and respiratory illnesses require regular monitoring, which elevates the demand for precise diagnostic tools like clinical analyzers. Furthermore, the advancements in biomedical technology have led to the development of more innovative and efficient analyzers that can provide faster results and demand less manual intervention. The shift towards personalized medicine also elevates the need for sophisticated testing equipment, as healthcare providers aim to tailor treatments based on individual patient profiles. Additionally, the rising geriatric population and their associated healthcare needs significantly contribute to the market's growth, as older adults are generally more susceptible to various health issues requiring regular monitoring. The global push towards enhancing healthcare systems, particularly in developing regions, is another crucial factor fostering growth in the clinical analyzer market.

Key Highlights of the Market

• The market is projected to grow at a CAGR of 6.5% during the forecast period from 2025 to 2035.
• North America currently holds the largest market share, followed closely by Europe and Asia Pacific.
• The demand for automation and AI-driven analyzers is rapidly increasing, enhancing efficiency in diagnostics.
• Immunoassay analyzers are among the fastest-growing product types, driven by advancements in disease detection.
• Hospital settings are the primary end users, significantly impacting product demand and market growth.

By Product Type

Chemistry Analyzers:

Chemistry analyzers are crucial tools in clinical diagnostics, enabling the analysis of chemical components in bodily fluids, primarily blood. These analyzers are pivotal in assessing organ function, diagnosing diseases, and monitoring therapeutic drug levels. Their efficiency in carrying out a wide range of tests simultaneously has made them essential in both hospital and laboratory settings. The continuous advancements in technology, such as microfluidics and automation, have significantly improved the accuracy and speed of results obtained from chemistry analyzers. The growing adoption of these systems across various healthcare facilities largely stems from their ability to deliver quick and reliable results, thereby enhancing clinical decision-making processes.

Immunoassay Analyzers:

Immunoassay analyzers represent a rapidly growing segment within the clinical analyzer market, primarily due to their role in the detection of specific antibodies or antigens in biological samples. These analyzers are widely utilized in the diagnosis of conditions like infectious diseases, hormonal disorders, and allergies. The increased focus on early detection and personalized medicine has driven the demand for highly sensitive immunoassay technologies. As these analyzers continue to evolve, innovations such as point-of-care testing and automated processing systems are expected to further enhance their adoption in clinical settings. Furthermore, the rise in chronic diseases and the need for regular monitoring of therapeutic agents continue to fuel the growth of immunoassay analyzers globally.

Hematology Analyzers:

Hematology analyzers are specifically designed to analyze blood samples to evaluate various parameters such as red blood cell count, white blood cell count, and platelet count. This type of analyzer plays a critical role in diagnosing blood disorders, infections, and other systemic conditions. The increasing prevalence of hematological diseases, alongside advancements in technology that allow for more comprehensive blood analysis, has significantly bolstered the demand for hematology analyzers. The development of automated systems that provide rapid results with minimal human intervention has revolutionized blood testing, making these analyzers indispensable in both hospitals and laboratories. Moreover, the ongoing research and development efforts aimed at improving the accuracy and efficiency of these devices are expected to drive market growth further.

Coagulation Analyzers:

Coagulation analyzers are essential in assessing the blood’s ability to clot, which is crucial for diagnosing various coagulation disorders and monitoring patients on anticoagulant therapy. The rising incidence of cardiovascular diseases and the increased awareness about the importance of coagulation monitoring have driven the demand for these specialized analyzers. Technological advancements leading to more automated, faster, and more accurate testing solutions have also contributed significantly to their adoption. Furthermore, the emergence of point-of-care coagulation testing devices is enhancing accessibility and enabling healthcare providers to make timely clinical decisions, thereby propelling the growth of this segment within the clinical analyzer market.

Microbiology Analyzers:

Microbiology analyzers are designed to detect and identify microorganisms in clinical specimens, facilitating the diagnosis of infectious diseases. The growing global burden of infectious diseases, coupled with the demand for more rapid and precise diagnostic tools, is driving the expansion of this segment. These analyzers utilize advanced technologies, including molecular diagnostics and culture-based methods, to deliver accurate results. The rising prevalence of antibiotic-resistant pathogens further emphasizes the need for effective microbiological testing, as accurate identification is crucial for appropriate treatment. This segment is anticipated to witness robust growth due to the increasing investment in clinical laboratories and advancements in microbiological testing technology.

By Application

Hospitals:

Hospitals are one of the primary applications driving the clinical analyzer market due to the comprehensive healthcare services they provide. With the increasing patient population and the demand for timely diagnostic services, hospitals are increasingly adopting advanced clinical analyzers to enhance their laboratory efficiency and accuracy. The necessity for quick diagnosis and treatment decisions in emergency care settings further emphasizes the importance of rapid testing capabilities that clinical analyzers offer. Additionally, hospitals are investing in automated systems to reduce turnaround time and improve patient outcomes, significantly propelling market growth in this segment. The continuous expansion of hospital infrastructure, particularly in developing regions, is also expected to support the demand for clinical analyzers in the foreseeable future.

Diagnostic Laboratories:

Diagnostic laboratories play a vital role in the clinical analyzer market, providing essential testing services to support disease diagnosis and treatment monitoring. These laboratories are increasingly adopting advanced analyzers to meet the growing demand for accurate and efficient testing. The rising burden of chronic diseases and infectious diseases necessitates comprehensive testing services, thereby driving the growth of diagnostic laboratories. Moreover, the trend towards outsourcing laboratory services to specialized diagnostic centers is further boosting the demand for clinical analyzers. The ongoing advancements in laboratory automation and integration of information technology systems are also enhancing laboratory efficiency, which in turn supports market growth in this segment.

Research Institutes:

Research institutes contribute significantly to the clinical analyzer market by utilizing these tools for various scientific studies and clinical trials. The need for precise and reliable data is paramount in research settings, driving the adoption of advanced clinical analyzers for experiments and investigations. As the focus on innovation in healthcare continues to grow, research institutes are investing in the latest analyzer technologies to enhance their research capabilities. Furthermore, collaborations between research organizations and diagnostic companies are becoming increasingly common, facilitating the development of new diagnostic assays and expanding the applications of clinical analyzers. This segment is expected to experience steady growth as research institutions continue to prioritize the adoption of cutting-edge technologies in their operations.

By End User

Hospitals:

Hospitals remain one of the largest end users of clinical analyzers, as they provide a broad range of diagnostic services essential for patient care. With the increasing patient influx and the demand for rapid diagnostic services, hospitals are investing heavily in modern clinical analyzers to enhance laboratory efficiency. The integration of laboratory information systems with clinical analyzers helps reduce errors, streamline workflows, and improve patient outcomes. Moreover, the growing emphasis on quality healthcare and patient satisfaction drives hospitals to adopt advanced technologies that enable timely diagnosis and treatment. As healthcare infrastructure expands globally, particularly in developing regions, the role of hospitals in driving clinical analyzer adoption is expected to remain significant.

Diagnostic Centers:

Diagnostic centers are critical players in the clinical analyzer market, focusing solely on providing laboratory testing services. With the increasing demand for diagnostic testing, these centers are investing in advanced clinical analyzers to meet the needs of a diverse patient population. The convenience and accessibility of diagnostic centers, particularly in urban areas, are driving their growth, leading to higher utilization of clinical analyzer technology. Furthermore, the trend of direct-to-consumer testing is gaining traction, with more individuals opting for testing services at diagnostic centers, thereby increasing their reliance on efficient and accurate clinical analyzers. As these centers continue to expand their service portfolios, the demand for innovative diagnostics will subsequently rise, influencing market growth positively.

Research Institutes:

Research institutes are instrumental in the advancement of medical science and diagnostics, utilizing clinical analyzers for various studies and clinical trials. These settings require high-precision testing to ensure the validity of research results, motivating investments in state-of-the-art analyzers. The focus on translational research and development of novel diagnostic assays is prompting research institutes to enhance their laboratory capabilities through innovative technologies. Collaboration between research facilities and commercial diagnostic manufacturers is becoming more prevalent, driving the evolution of clinical analyzers tailored for research applications. As the clinical research landscape continues to grow, the demand for advanced analyzers within research institutes is expected to see a corresponding rise, fostering market growth.

By Product Modality

Benchtop Analyzers:

Benchtop analyzers are compact laboratory devices designed to deliver diagnostic results in smaller laboratory settings. Their popularity is attributed to their space-saving design, ease of use, and efficiency in performing a wide range of tests. These analyzers are particularly favored by smaller laboratories and clinics that require versatile and reliable diagnostic solutions. The advancements in technology have enabled benchtop analyzers to incorporate sophisticated features such as automated sample handling and integrated data management systems, enhancing their appeal. As the demand for point-of-care testing increases, benchtop analyzers are expected to play a significant role in providing timely diagnostic services, thereby contributing to the overall growth of the clinical analyzer market.

Floor-standing Analyzers:

Floor-standing analyzers are larger, more sophisticated devices typically used in high-throughput laboratory settings such as hospitals and large diagnostic laboratories. These analyzers are designed to process a significant volume of samples and offer enhanced capabilities for complex testing. The demand for floor-standing analyzers is largely driven by the need for efficiency in clinical diagnostics, as they can perform multiple tests simultaneously and provide rapid results. Innovations in automation and technology integration have made these analyzers more reliable and user-friendly, further contributing to their adoption. As healthcare facilities seek to improve operational efficiency and patient outcomes, the floor-standing analyzer segment is anticipated to witness robust growth in the coming years.

Portable Analyzers:

Portable analyzers have gained significant traction in the clinical analyzer market due to their convenience and flexibility. These devices are designed for use in various settings, including point-of-care testing, remote locations, and emergency situations. The ability to obtain quick and accurate results at the patient's bedside or in field conditions is driving the growth of portable analyzers. Technological advancements have enabled the development of portable devices that maintain high levels of accuracy and reliability comparable to traditional laboratory analyzers. As the emphasis on timely healthcare delivery continues to rise, the demand for portable analyzers is expected to grow, enhancing their presence in the clinical diagnostics landscape.

By Region

North America holds the largest share of the clinical analyzer market, accounting for approximately 38% of the global market due to its advanced healthcare infrastructure, high adoption rates of innovative technologies, and significant investment in research and development. The U.S. is a major contributor to this segment, driven by the presence of key market players and a growing emphasis on early disease diagnosis. The market in North America is expected to grow at a CAGR of 5.8% over the forecast period, reflecting the continuous need for efficient diagnostic solutions in hospitals, diagnostic laboratories, and research institutes. Regulatory support and favorable reimbursement policies further bolster the growth of clinical analyzers in this region.

Europe follows closely, holding a substantial share of the clinical analyzer market, driven by the increasing prevalence of chronic diseases and the growing demand for diagnostic services. The European region is characterized by a strong emphasis on healthcare quality and patient outcomes, leading to significant investments in advanced clinical analyzer technologies. The expanding network of diagnostic laboratories and hospitals in countries such as Germany, France, and the UK is expected to propel market growth. The Asia Pacific region is also witnessing rapid growth, anticipated to experience the highest CAGR of 8.2% during the forecast period due to rising healthcare expenditures, improving healthcare infrastructure, and increasing awareness of preventive healthcare. Other emerging regions such as Latin America and the Middle East & Africa are also expected to see considerable growth in the clinical analyzer market due to rising healthcare investments and a growing focus on advancing diagnostic capabilities.

Opportunities

The clinical analyzer market presents numerous opportunities for growth, particularly through the integration of advanced technologies such as artificial intelligence (AI) and machine learning. These technologies can significantly enhance the efficiency and accuracy of diagnostic processes, leading to improved patient outcomes and streamlined laboratory operations. As healthcare providers increasingly seek to reduce errors and improve turnaround times, the demand for AI-enabled clinical analyzers is likely to rise. Furthermore, the expanding trend towards personalized medicine offers a significant opportunity for the development of specialized diagnostic assays tailored to individual patient needs. This shift towards personalized healthcare is anticipated to drive innovation and expand the clinical analyzer product portfolio, creating additional market opportunities.

Another significant opportunity lies in the growing demand for point-of-care testing (POCT) solutions, particularly in remote and underserved areas. The convenience and accessibility of portable clinical analyzers facilitate timely diagnostics in various settings, including home healthcare and rural clinics. As the global healthcare landscape evolves, there is an increasing focus on decentralizing healthcare services, leading to a surge in demand for POCT devices. Companies that invest in developing compact, user-friendly, and cost-effective analyzers suitable for point-of-care applications are likely to gain a competitive advantage. Additionally, partnerships and collaborations between diagnostic manufacturers and healthcare providers can enhance market reach and drive the growth of the clinical analyzer market.

Threats

Despite the promising growth potential, the clinical analyzer market faces several threats that could hinder its progress. One of the most significant challenges is the stringent regulatory environment governing the approval and commercialization of medical devices. Compliance with various international standards and regulations can be a lengthy and complex process, impacting the speed at which new products are brought to market. Additionally, the rapid pace of technological advancements means that companies must continuously innovate to stay competitive, which can strain resources and affect profitability. Furthermore, the increasing prevalence of counterfeit and substandard diagnostic devices poses a significant threat to market integrity and patient safety. These challenges necessitate a proactive approach from companies to ensure compliance and maintain the trust of healthcare providers and patients.

Another critical concern for the clinical analyzer market is the potential for data security breaches as laboratories increasingly adopt digital solutions for managing results and patient information. Cybersecurity threats pose a risk to sensitive patient data, which can lead to significant financial and reputational damage for healthcare providers. Companies must invest in robust cybersecurity measures to protect their digital assets and maintain compliance with data protection regulations. Moreover, the ongoing global supply chain disruptions caused by geopolitical tensions and pandemics can impact the availability of essential components for clinical analyzers, further exacerbating market instability. These threats necessitate vigilance and strategic planning from market participants to navigate an increasingly complex landscape.

Competitor Outlook

• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Beckman Coulter (a subsidiary of Danaher Corporation)
• Thermo Fisher Scientific
• Sysmex Corporation
• Ortho Clinical Diagnostics
• Mindray Medical International Limited
• Horiba Medical
• Bio-Rad Laboratories
• PerkinElmer, Inc.
• Agilent Technologies
• F. Hoffmann-La Roche AG
• Canon Medical Systems Corporation
• Trivitron Healthcare

The competitive landscape of the clinical analyzer market is characterized by the presence of several major players who continuously strive to innovate and enhance their product offerings. Companies such as Roche Diagnostics and Abbott Laboratories have established themselves as leaders in the market, leveraging their extensive research and development capabilities to introduce advanced clinical analyzer technologies. These companies are also focusing on strategic partnerships and collaborations to expand their market reach and enhance their product portfolios. Additionally, the trend of mergers and acquisitions among key players is shaping the competitive dynamics, as companies seek to consolidate their positions and capitalize on synergies. The emphasis on automation and digitalization in laboratory processes is prompting competition among manufacturers to develop integrated solutions that cater to evolving customer needs.

Another critical aspect of the competitive landscape is the focus on customer-centric solutions, where companies are investing in tailored products and services to meet the specific needs of their end users. For example, firms like Siemens Healthineers and Thermo Fisher Scientific are prioritizing user-friendly interfaces, enhanced diagnostic accuracy, and rapid turnaround times in their product development efforts. Furthermore, the increasing demand for point-of-care testing is encouraging competitors to innovate portable and compact analyzers that meet the requirements of diverse healthcare settings. As the market continues to evolve, companies that can effectively leverage technology and respond to the changing demands of healthcare providers are likely to emerge as frontrunners.

Several notable companies are making significant strides in the clinical analyzer market, each contributing unique strengths and innovations. Roche Diagnostics, a subsidiary of Roche Holding AG, is renowned for its extensive range of diagnostic solutions, including clinical analyzers that enhance the speed and accuracy of laboratory testing. The company’s commitment to research and development enables it to maintain a leading position in the market, continually offering cutting-edge technologies. Similarly, Abbott Laboratories has established a strong reputation for its advanced diagnostic products, including a wide array of clinical analyzers that cater to various testing needs. The integration of automation and AI in their devices enhances efficiency and supports healthcare providers in delivering timely results.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Horiba Medical
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 PerkinElmer, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Roche Diagnostics
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Sysmex Corporation
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Abbott Laboratories
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Agilent Technologies
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Bio-Rad Laboratories
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Siemens Healthineers
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Trivitron Healthcare
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 F. Hoffmann-La Roche AG
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Thermo Fisher Scientific
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Ortho Clinical Diagnostics
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Canon Medical Systems Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Mindray Medical International Limited
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Beckman Coulter (a subsidiary of Danaher Corporation)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Clinical Analyzer Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Diagnostic Centers
    • 6.1.3 Research Institutes
  • 6.2 Clinical Analyzer Market, By Application
    • 6.2.1 Hospitals
    • 6.2.2 Diagnostic Laboratories
    • 6.2.3 Research Institutes
  • 6.3 Clinical Analyzer Market, By Product Type
    • 6.3.1 Chemistry Analyzers
    • 6.3.2 Immunoassay Analyzers
    • 6.3.3 Hematology Analyzers
    • 6.3.4 Coagulation Analyzers
    • 6.3.5 Microbiology Analyzers
  • 6.4 Clinical Analyzer Market, By Product Modality
    • 6.4.1 Benchtop Analyzers
    • 6.4.2 Floor-standing Analyzers
    • 6.4.3 Portable Analyzers

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Clinical Analyzer Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Clinical Analyzer market is categorized based on

By Product Type

• Chemistry Analyzers
• Immunoassay Analyzers
• Hematology Analyzers
• Coagulation Analyzers
• Microbiology Analyzers

By Application

• Hospitals
• Diagnostic Laboratories
• Research Institutes

By End User

• Hospitals
• Diagnostic Centers
• Research Institutes

By Product Modality

• Benchtop Analyzers
• Floor-standing Analyzers
• Portable Analyzers

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Beckman Coulter (a subsidiary of Danaher Corporation)
• Thermo Fisher Scientific
• Sysmex Corporation
• Ortho Clinical Diagnostics
• Mindray Medical International Limited
• Horiba Medical
• Bio-Rad Laboratories
• PerkinElmer, Inc.
• Agilent Technologies
• F. Hoffmann-La Roche AG
• Canon Medical Systems Corporation
• Trivitron Healthcare